Biosynth has officially opened its expanded GMP bioconjugation facility in Berlin, further strengthening its global manufacturing network and CDMO services. The upgrade enhances production of conjugate vaccines and drugs, activated PEGs, and polymer-based excipients used in drug delivery. The expansion includes
Biosynth is a Distributor/Import Export, Manufacturer/Innovator, Academic/Research, Contract Service, CMO/CDMO, Contract Research Organisation (CRO) company operating in the pharmaceutical industry. Securing Life Sciences Supply Chains – where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
